down arrow

Halozyme Therapeutics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US40637H1095
USD
65.11
0.64 (0.99%)

Dec 18

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
363.82
83.81
169.80
196.95
151.05
91.77
Shareholder's Funds
363.82
83.81
169.80
196.95
151.05
91.77
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
1,512.85
1,499.25
1,506.10
876.67
397.23
402.59
Secured Loans
1,512.85
1,499.25
1,506.10
876.67
397.23
402.59
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-3.86
-4.39
-44.43
-155.43
0.00
0.00
Other Long Term Liabilities
155.16
37.72
48.16
3.07
7.49
5.43
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
15.47
0.00
0.00
0.00
Total Non-Current Liabilities
1,660.96
1,536.97
1,540.92
790.33
7.49
388.47
Current Liabilities
Trade Payables
10.25
11.82
17.69
1.54
1.93
6.43
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
15.47
0.00
0.00
0.00
Total Current Liabilities
139.10
112.49
130.79
117.15
421.38
85.64
Total Liabilities
2,163.88
1,733.27
1,841.51
1,104.43
579.92
565.87
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
100.46
94.61
90.33
21.89
22.18
21.60
Less: Accumulated Depreciation
25.43
19.66
14.76
13.10
11.58
10.74
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
75.03
74.94
75.57
8.79
10.59
10.86
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
1.60
0.00
0.50
0.50
0.50
0.50
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
79.00
17.82
26.30
13.41
14.07
11.08
Total Non-Current Assets
1,078.54
986.85
1,102.50
178.14
25.16
22.44
Current Assets Loans & Advances
Current Investments
480.22
217.63
128.60
622.20
220.31
301.08
Inventories
141.86
127.60
100.12
53.91
60.75
29.36
Sundry Debtors
308.45
234.21
231.07
90.97
97.73
59.44
Cash and Bank
115.85
118.37
234.19
118.72
147.70
120.18
Other Current Assets
1,046.39
697.81
693.99
885.81
526.49
510.06
Short Term Loans and Advances
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Assets
1,085.34
746.42
739.01
926.29
554.76
543.44
Net Current Assets (Including Current Investments)
946.24
633.93
608.22
809.14
133.38
457.80
Total Current Assets Excluding Current Investments
1,085.34
746.42
739.01
926.29
554.76
543.44
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
2,163.88
1,733.27
1,841.51
1,104.43
579.92
565.87
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
1,512.85
1,499.25
1,506.10
876.67
397.23
402.59
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Dec 2024 is 0.44% vs 0.43% in Dec 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2024 is 311.35% vs -21.68% in Dec 2023

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2024 is 0.12% vs -0.83% in Dec 2023

stock-summary

Investments

YoY Growth in year ended Dec 2024 is 0.00% vs -100.00% in Dec 2023

stock-summary

Current Assets

YoY Growth in year ended Dec 2024 is 45.41% vs 1.00% in Dec 2023

Compare Balance Sheet Results of Halozyme Therapeutics, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
363.82
6,096.00
-5,732.18
-94.03%
Shareholder's Funds
363.82
6,096.00
-5,732.18
-94.03%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
1,512.85
4,352.00
-2,839.15
-65.24%
Secured Loans
1,512.85
4,352.00
-2,839.15
-65.24%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
-3.86
449.00
-452.86
-100.86%
Other Long Term Liabilities
155.16
926.00
-770.84
-83.24%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
175.00
-175.00
-100.00%
Total Non-Current Liabilities
1,660.96
5,203.00
-3,542.04
-68.08%
Current Liabilities
Trade Payables
10.25
296.00
-285.75
-96.54%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
175.00
-175.00
-100.00%
Total Current Liabilities
139.10
1,315.00
-1,175.90
-89.42%
Total Liabilities
2,163.88
12,614.00
-10,450.12
-82.85%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
100.46
1,973.00
-1,872.54
-94.91%
Less: Accumulated Depreciation
25.43
858.00
-832.57
-97.04%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
75.03
1,115.00
-1,039.97
-93.27%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
1.60
17.00
-15.40
-90.59%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
79.00
172.00
-93.00
-54.07%
Total Non-Current Assets
1,078.54
9,399.00
-8,320.46
-88.52%
Current Assets Loans & Advances
Current Investments
480.22
0
480.22
0.00%
Inventories
141.86
1,574.00
-1,432.14
-90.99%
Sundry Debtors
308.45
805.00
-496.55
-61.68%
Cash and Bank
115.85
468.00
-352.15
-75.25%
Other Current Assets
1,046.39
3,049.00
-2,002.61
-65.68%
Short Term Loans and Advances
0
202.00
-202.00
-100.00%
Total Current Assets
1,085.34
3,215.00
-2,129.66
-66.24%
Net Current Assets (Including Current Investments)
946.24
1,900.00
-953.76
-50.20%
Total Current Assets Excluding Current Investments
1,085.34
3,215.00
-2,129.66
-66.24%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
2,163.88
12,614.00
-10,450.12
-82.85%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
1,512.85
4,352.00
-2,839.15
-65.24%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 1,505.80 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 0.44% vs 0.43% in Dec 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 155.16 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 311.35% vs -21.68% in Dec 2023

Annual - Fixed Assets
Fixed Assets 75.03 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 0.12% vs -0.83% in Dec 2023

Annual - Investments
Investments 1.60 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 0.00% vs -100.00% in Dec 2023

Annual - Current Assets
Current Assets 1,085.34 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 45.41% vs 1.00% in Dec 2023

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."